| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 7.61 mm | 7.61 mm | 7.61 mm | 7.61 mm | 7.61 mm | |
| Cash burn (monthly) | 3.41 mm | 257.82 k | 1.80 mm | 1.45 mm | 871.65 k | |
| Cash used (since last report) | 9.60 mm | 726.48 k | 5.08 mm | 4.09 mm | 2.46 mm | |
| Cash remaining | -1.99 mm | 6.88 mm | 2.53 mm | 3.53 mm | 5.16 mm | |
| Runway (months of cash) | -0.6 | 26.7 | 1.4 | 2.4 | 5.9 | |
| 13F holders | Current |
|---|---|
| Total holders | 14 |
| Opened positions | 5 |
| Closed positions | 11 |
| Increased positions | 3 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 1.11 bn |
| Total shares | 13.68 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| PMCB PharmaCyte Biotech | 12.71 mm | $11.82 mm |
| CM Management | 425.00 k | $484.50 mm |
| Clear Creek Financial Management | 317.47 k | $361.92 mm |
| STT State Street | 56.37 k | $64.26 mm |
| RY Royal Bank of Canada | 52.94 k | $60.00 mm |
| HB Wealth Management | 35.47 k | $40.43 mm |
| Tri Locum Partners | 30.61 k | $34.89 mm |
| Whittier Trust Co Of Nevada | 15.88 k | $17.95 mm |
| Two Sigma Securities | 15.71 k | $17.90 mm |
| Creative Planning | 10.53 k | $12.00 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Jul 24 | Alistair Milnes | Stock Option Common Stock | Grant | Acquire A | No | No | 1.14 | 17,600 | 20.06 k | 17,600 |
| 12 Jul 24 | Edward R Uzialko | Stock Option Common Stock | Grant | Acquire A | No | No | 1.14 | 17,600 | 20.06 k | 17,600 |
| 12 Jul 24 | Silverman Joshua | Stock Option Common Stock | Grant | Acquire A | No | No | 1.14 | 17,600 | 20.06 k | 17,600 |
| 12 Jul 24 | Charles Larsen | Stock Option Common Stock | Grant | Acquire A | No | No | 1.14 | 17,600 | 20.06 k | 17,600 |
| 12 Feb 24 | Richard D. Spector | Stock Option Common Stock | Grant | Acquire A | No | No | 1.1 | 100,000 | 110.00 k | 100,000 |
